Alexion to Acquire Rare Disease Specialist Wilson Therapeutics

By Natasha Piper

Pharma Deals Review: Vol 2018 Issue 4 (Table of Contents)

Published: 26 Apr-2018

DOI: 10.3833/pdr.v2018.i4.2322     ISSN: 1756-7874

Section: Mergers & Acquisitions

Fulltext:

Abstract

Alexion Pharmaceuticals has made an all-cash offer to acquire Wilson Therapeutics for a total of SEK7...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details